ST14, suppression of tumorigenicity 14, 6768

N. diseases: 170; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 AlteredExpression group BEFREE This study aimed to examine the genetic variation of matriptase (ST14 gene) and HAI-1 (SPINT1 gene) in breast cancer risk and prognosis, to assess matriptase and HAI-1 gene and protein expression in breast tumors, and to identify their clinicopathologic correlations and prognostic significance. 20716618 2010
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 AlteredExpression group LHGDN To explore the clinical relevance of our model, we examined expression levels of three genes involved in activation of the MSP signaling pathway (MSP, MT-SP1, and MST1R) in human breast tumors. 17456594 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 Biomarker group BEFREE To explore the clinical relevance of our model, we examined expression levels of three genes involved in activation of the MSP signaling pathway (MSP, MT-SP1, and MST1R) in human breast tumors. 17456594 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.030 AlteredExpression group LHGDN Deregulated activation of matriptase in breast cancer cells. 12498394 2002